z-logo
open-access-imgOpen Access
MP76-12 REGULAR LOW DOSE SILDENAFIL REDUCES VENOUS LEAK RATES AFTER RADICAL PROSTATECTOMY
Author(s) -
Raanan Tal,
Bob Berookhim,
Doron S. Stember,
Lawrence C. Jenkins,
Joe Narus,
David García,
Natalie C. Wolchasty,
John P. Mulhall
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.1863
Subject(s) - medicine , prostatectomy , erectile dysfunction , sildenafil , urology , papaverine , erectile function , sexual function , surgery , prostate cancer , cancer
days preceding visits. Quality of life (QoL) was assessed by the SF36 questionnaire at Weeks 1 and 52 (end of study). RESULTS: Hypogonadal subjects with SD were significantly older (p1⁄40.001), and had lower serum estradiol levels (p1⁄40.043); baseline T levels were not significantly different. Sexual desire and activity, which were similar in both groups at baseline, improved to a similar extent in each group. In men with and without SD, LPCN 1021 significantly improved penile rigidity (p<0.001 and p1⁄40.028, respectively) and ability to maintain an erection (p<0.001 and p1⁄40.007, respectively). Non-significant differences were observed for the same with T gel 1.62%. In addition, LPCN 1021 significantly improved depressed mood (p1⁄40.002), mental health (p1⁄40.023) and mental component summary (p1⁄40.008) in hypogonadal subjects with SD. CONCLUSIONS: Conclusions: Twice daily administration of oral LPCN 1021 over 52 weeks improved several parameters of sexual function in hypogonadal men with SD prior to treatment. 1Cunningham GR, et al. J Clin Endocrinol Metab. 2015 Mar;100(3):1146-55.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom